Canadian Innovations
Canadians Pioneered the Innovation. Novatlantic will take the lead in commercializing it on an international scale
Stop letting MENA market complexity limit your regional impact. Novatlantic serves as your dedicated Middle East and North Africa commercial partner, transforming your breakthrough Canadian therapies into accessible treatments for 400+ million MENA patients
Novatlantic MENA Solutions
We de-risk and accelerate MENA market entry, enabling efficient resource allocation while you maintain focus on innovation. Our model provides immediate access to established MENA networks built over 25+ years, regulatory expertise across all regional markets, and commercial infrastructure that would require years and millions of dollars to build independently.
MENA Market Entry Consultation
In a focused 30-minute discussion, we will review your innovation, assess MENA market opportunities across Saudi Arabia, UAE, Egypt, and other target countries, and outline a strategic pathway for your Middle East and North Africa expansion into a healthcare market valued at over USD 256 billion.
Our initial consultations provide actionable MENA-specific insights including regulatory pathway recommendations, distributor screening criteria, and realistic timeline projections—regardless of whether you choose to engage our services